Lysergic Acid Diethylamide Induces Transcriptional Changes Opposing Signatures of Brain Ageing and Neurodegeneration
Key claim: Lysergic acid diethylamide (LSD) induces transcriptional profiles in the brain that oppose molecular signatures of aging and neurodegeneration.
Abstract
Aging Cell, Volume 25, Issue 11, November 2026.
Why this matters
[mechanism-plausible] This finding adds a molecular rationale to psychedelic healthy-aging research, but opposing an aging-associated gene-expression signature is not equivalent to reversing brain aging or preventing neurodegenerative disease. [mechanism-plausible] It extends the page’s mechanistic evidence record without establishing human benefit or safety; the finding supplies no media/community evidence with which to assess trend momentum.